Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eric-Jan Kroot"'
Autor:
Mart van de Laar, Tim Jansen, A Willemze, Y P M Goekoop-Ruiterman, Reinhard Bos, Eric-Jan Kroot, Celine J van de Laar, Martijn A H Oude Voshaar, Peter ten Klooster, Danyta I Tedjo, Grada A Versteeg
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To compare the effectiveness of a strategy administering baricitinib versus one using TNF-inhibitors (TNFi) in patients with rheumatoid arthritis (RA) after conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) failure in
Externí odkaz:
https://doaj.org/article/1b9ec324618846a0b242f9eee2c79699
Publikováno v:
Psoriatic arthritis.
Background Recent data suggest that patients with moderately active psoriatic arthritis (PsA) and a limited number of active joints have a high likelihood of achieving treatment goals with apremilast treatment.1,2 Real-world evidence on the effect of
Autor:
Jacques M.G.W. Wouters, Mario Maas, Maarten C. Kraan, Tom J. M. Smeets, Peter Paul Tak, Eric-Jan Kroot
Publikováno v:
Annals of the Rheumatic Diseases, 64(3), 497-499. BMJ Publishing Group
Annals of the rheumatic diseases, 64(3), 497-499. BMJ Publishing Group
Annals of the rheumatic diseases, 64(3), 497-499. BMJ Publishing Group
Background: Pigmented villonodular synovitis (PVNS) is considered to be a neoplastic-like disorder of the synovium histologically characterised by villonodular hyperplasia, resulting in dense fibrosis and haemosiderin deposition. The pathogenesis of
Autor:
Henk C. Van Paassen, Eric-Jan Kroot, Jacques M.G.W. Wouters, A. Margriet Huisman, Jende van Zeben
Publikováno v:
Annals of the New York Academy of Sciences. 1069
Pulse therapy with high-dose glucocorticoids (GCs) is widely used as "bridging therapy" for the treatment of patients with active rheumatoid arthritis (RA). Oral pulsed dexamethasone therapy has never been used for this purpose. We determined the cli
Autor:
Eric-Jan Kroot
Publikováno v:
Clinical Nuclear Medicine; Aug2006, Vol. 31 Issue 8, p501-503, 3p